Kalemapex 30 tablets
Apex Pharma
Apex Pharma
Ingredients
Potassium citrate - 15 mEq (1620 mg).
Description
Potassium citrate-based medication for correction of metabolic acidosis and prevention of kidney stones. Alkalinizes urine, increases citrate levels (inhibitor of calcium salt crystallization), and reduces risk of calcium oxalate and urate stone formation.
Indications
-Renal tubular acidosis with calcium stones.
-Hypocitraturic calcium oxalate nephrolithiasis.
-Uric acid lithiasis (with or without calcium stones).
Dosage and Administration
Dosage: 1 tablet (1080–1620 mg potassium citrate) 2–3 times daily with meals.
Dose adjustment: based on urinary pH (target: 6.0–7.0) and citraturia levels.
Requirements: strict low-salt diet and fluid intake ≥2 L/day.
Contraindications
-Hyperkalemia.
-Chronic renal failure (GFR <0.7 mL/kg/min).
-GI disorders: peptic ulcer disease, intestinal obstruction.
-Use of potassium-sparing diuretics (spironolactone, triamterene).
-Active urinary tract infections.
Precautions
-Regular monitoring of electrolytes (K⁺, Na⁺, Cl⁻, CO₂), creatinine, and CBC every 4 months.
-ECG monitoring in patients with cardiovascular diseases.
-Immediate withdrawal if hyperkalemia or GI ulcers occur.
Adverse Reactions
-Gastrointestinal disorders (nausea, vomiting, diarrhea).
-Hyperkalemia (life-threatening!).
-Risk of intestinal ulcers/stenosis.
-Intact tablet matrices in stool.
Pregnancy and Lactation
Pregnancy: use only if strictly necessary (no safety data).
Lactation: caution advised (potassium excreted in breast milk).
Storage
Store at temperatures not exceeding 30°C in a dry place.
Keep out of reach of children.
Package
Carton box containing 3 blisters (10 tablets each) + leaflet.